The cytokine network in acute myeloid leukemia

The cytokine network in acute myeloid leukemia

Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid disease progression. Chemotherapy has been the first-line treatment for AML for more than 30 years. Application of recent h...

Full description

Bibliographic Details
Main Authors:	Michela Luciano, Peter W. Krenn, Jutta Horejs-Hoeck
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Immunology
Subjects:	acute myeloid leukemia cytokine signaling inflammation tumor microenvironment cytokine inhibitors
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1000996/full

Similar Items

The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia
by: Laura Urwanisch, et al.
Published: (2021-01-01)

The Relationship between Fatigue and Cytokine Levels in Patients with Acute Myeloid Leukemia
by: Malihe Khosravi, et al.
Published: (2018-08-01)

Hedgehog/GLI signaling in hematopoietic development and acute myeloid leukemia—From bench to bedside
by: Suzana Tesanovic, et al.
Published: (2022-08-01)

Assessment of Cytokine Expression Profile in Acute Myeloid Leukemia Patients Before and After Chemotherapy
by: Zargham Sepehrizadeh, et al.
Published: (2014-05-01)

ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
by: Ran Li, et al.
Published: (2022-08-01)

Checkpoint Inhibitors in Acute Myeloid Leukemia
by: Daniela Damiani, et al.
Published: (2023-06-01)

Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies
by: Virginia Camacho, et al.
Published: (2021-11-01)

Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity
by: Ida Sofie Grønningsæter, et al.
Published: (2021-08-01)

Cytokine profile in patients with chronic myeloid leukemia
by: T. N. Aleksandrova, et al.
Published: (2024-01-01)

Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators
by: Elise Aasebø, et al.
Published: (2018-12-01)

Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products
by: Christopher Hino, et al.
Published: (2022-06-01)

The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome
by: Annette K. Brenner, et al.
Published: (2019-01-01)

Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia
by: Claudia Bănescu, et al.
Published: (2019-09-01)

Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
by: Stephanie Sendker, et al.
Published: (2021-03-01)

Evaluation of cytokines and soluble adhesion molecules in patients with newly diagnosed acute myeloid leukemia: the role of TNF-alpha and FLT3-ITD
by: Tomas Kupsa, et al.
Published: (2016-03-01)

Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective
by: Yunyi Wu, et al.
Published: (2024-02-01)

Serum cytokine and adhesion molecule profile differs in newly diagnosed acute myeloid and lymphoblastic leukemia
by: Jan M. Horacek, et al.
Published: (2015-06-01)

Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition
by: Marte Karen Brattås, et al.
Published: (2022-11-01)

Dissecting the Immune Landscape of Acute Myeloid Leukemia
by: Jan Davidson-Moncada, et al.
Published: (2018-11-01)

An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment
by: Tiziana Grafone, et al.
Published: (2012-04-01)

Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia
by: Hui Zhou, et al.
Published: (2022-12-01)

Tumor Microenvironmental Competitive Endogenous RNA Network and Immune Cells Act as Robust Prognostic Predictor of Acute Myeloid Leukemia
by: Yaqi Cheng, et al.
Published: (2021-04-01)

Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing
by: Fangmin Zhong, et al.
Published: (2023-11-01)

Cytokines: Can Cancer Get the Message?
by: Rachel M. Morris, et al.
Published: (2022-04-01)

Combination Therapies with Kinase Inhibitors for Acute Myeloid Leukemia Treatment
by: Shinichiro Takahashi
Published: (2023-05-01)

The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective
by: Dimitrios Mougiakakos
Published: (2019-11-01)

Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia
by: Xiqin Tong, et al.
Published: (2023-04-01)

A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia
by: Başak Aru, et al.
Published: (2023-01-01)

Myeloid Sarcoma in an Eyelid That Developed during Chemotherapy for Acute Myeloid Leukemia
by: Hyera Kang, et al.
Published: (2016-01-01)

Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies
by: Luca Guarnera, et al.
Published: (2023-10-01)

Study of serum cytokines (interleukin-6 and tumor necrosis factor-alpha) in acute leukemias
by: Divita Saxena, et al.
Published: (2022-01-01)

Acute Myeloid Leukemia: analysis of epidemiological profile and survival rate
by: Mariana Cardoso de Lima, et al.
Published: (2016-05-01)

The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia
by: Xiuhua Su, et al.
Published: (2022-10-01)

Put in a “Ca<sup>2+</sup>ll” to Acute Myeloid Leukemia
by: Clara Lewuillon, et al.
Published: (2022-02-01)

A Case of Leukemia Cutis with Acute Myeloid Leukemia on Azacitidine Therapy
by: Asude Kara, et al.
Published: (2017-05-01)

Identification of a prognostic model based on costimulatory molecule-related subtypes and characterization of tumor microenvironment infiltration in acute myeloid leukemia
by: Yan Mao, et al.
Published: (2022-08-01)

Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
by: Ivana Milosevic
Published: (2016-11-01)

Cytokines profiling as prognostic markers in newly diagnosed acute myeloid leukemia
by: Hiba Shakir Ahmed, et al.
Published: (2017-01-01)

Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable Phenotype
by: Annette K. Brenner, et al.
Published: (2019-07-01)

Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia
by: Jingjing Pan, et al.
Published: (2022-06-01)